Substantial evidence indicates that the abundance of tumor infiltrating lymphocytes in the microenvironment of certain tumor types is associated with the prognosis of cancer patients, and CD4+ T cells play a central role in regulating the immune response through their capacity to coordinate the functions of other immune cell types. The gene discussed is CD4; the disease is neoplasm.